Ashley Moffett
Auto-generated profile, based on publicly available information

Ashley Moffett

University of Cambridge

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in Nature
Verified
Journal Article
Closed access
PDF file
RVRoser Vento-Tormo
Roser Vento-Tormo
MEMirjana Efremova
Mirjana Efremova
RBRachel A. Botting
Rachel A. Botting
MTMargherita Y. Turco
Margherita Y. Turco
MVMiquel Vento-Tormo
Miquel Vento-Tormo
STSarah A. Teichmann
Sarah A. Teichmann

15 July 2019 in BMJ
Verified
Journal Article
Closed access
GBGraham J Burton
Graham J Burton
CRChristopher W Redman
Christopher W Redman
JRJames M Roberts
James M Roberts
AMAshley Moffett
Ashley Moffett
Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These systemic signs arise from soluble factors released from the placenta as a result of a response to stress of syncytiotrophoblast. There are two sub-types: early and late onset pre-eclampsia, with others almost certainly yet to be identified. Early onset pre-eclampsia arises owing to defective placentation, whilst late onset pre-eclampsia may center around interactions between normal senescence of the placenta and a maternal genetic predisposition to cardiovascular and metabolic disease. The causes, placental and maternal, vary among individuals. Recent research has focused on placental-uterine interactions in early pregnancy. The aim now is to translate these findings into new ways to predict, prevent, and treat pre-eclampsia.

1 September 2002 in Nature Reviews Immunology
Verified
Journal Article
Closed access
AMAshley Moffett-King
Ashley Moffett-King

11 October 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SHSusan E. Hiby
Susan E. Hiby
JWJames Johnston Walker
James Johnston Walker
KOKevin M. O'Shaughnessy
Kevin M. O'Shaughnessy
CRChristopher W.G. Redman
Christopher W.G. Redman
MCMary Carrington
Mary Carrington
AMAshley Moffett
Ashley Moffett
Preeclampsia is a serious complication of pregnancy in which the fetus receives an inadequate supply of blood due to failure of trophoblast invasion. There is evidence that the condition has an immunological basis. The only known polymorphic histocompatibility antigens on the fetal trophoblast are HLA-C molecules. We tested the idea that recognition of these molecules by killer immunoglobulin receptors (KIRs) on maternal decidual NK cells is a key factor in the development of preeclampsia. Striking differences were observed when these polymorphic ligand: receptor pairs were considered in combination. Mothers lacking most or all activating KIR (AA genotype) when the fetus possessed HLA-C belonging to the HLA-C2 group were at a greatly increased risk of preeclampsia. This was true even if the mother herself also had HLA-C2, indicating that neither nonself nor missing-self discrimination was operative. Thus, this interaction between maternal KIR and trophoblast appears not to have an immune function, but instead plays a physiological role related to placental development. Different human populations have a reciprocal relationship between AA frequency and HLA-C2 frequency, suggesting selection against this combination. In light of our findings, reproductive success may have been a factor in the evolution and maintenance of human HLA-C and KIR polymorphisms.

1 August 2006 in Nature Reviews Immunology
Verified
Journal Article
Closed access
AMAshley Moffett
Ashley Moffett
CLCharlie Loke
Charlie Loke

28 November 2018 in Nature
Verified
Journal Article
Closed access
PDF file
MTMargherita Y. Turco
Margherita Y. Turco
LGLucy Gardner
Lucy Gardner
RKRichard G. Kay
Richard G. Kay
RHRussell Hamilton
Russell Hamilton
MPMalwina Prater
Malwina Prater
AMAshley Moffett
Ashley Moffett